Gastric Leak after Laparoscopic Sleeve Gastrectomy

Document Type : Original Article

Author

Department of General Surgery, Ain Shams University, Egypt

Abstract

Background: Laparoscopic sleeve gastrectomy (LSG) has increased in popularity as a definitive bariatric operation. LSG had significant morbidity like stenosis, leak along the staple line, and bleeding. Gastric leak after LSG is serious and life threating complication. It requires high index of suspicion for early diagnosis and proper management.
 
Patients and methods: From September 2012 till October 2015, 120 morbidly obese patients with a mean BMI of 49±9 underwent laparoscopic sleeve gastrectomy (LSG) at Ain Shams University hospitals. LSG was discussed in details with the patients with emphasis on the benefits and more importantly the potential complications and side effects of LSG and written consent was taken.
 
Results: 120 patients underwent LSG at Ain Shams University hospitals from them 4 patients (3.3%) developed  a gastric leak. Of these 4 patients, 3 (75%) were women and 1 (25%) man. The patients had a mean age of 42.5 years and a body mass index (BMI) of 48.4 kg/m2. Leaks were diagnosed at a median of 7 days. All cases of leakage were managed conservative by antibiotics, proton pump inhibitor (PPI), total parenteral nutrition and a self-expanding stent was placed under fluoroscopic and endoscopic control (coated metallic stents). Mean healing time was 45 days (range 21–60), mean hospital stay was 10 days. No patient required reoperation and there was no mortality.
 
Conclusion: Gastric leak after LSG is low but serious and life threating complication. It required early
diagnosis and proper management. Conservative treatments are effective but require long hospital stay.
 

Keywords


 

Gastric Leak after Laparoscopic Sleeve Gastrectomy

 

Ahmed H. Ali, FRCS

Department of General Surgery, Ain Shams University, Egypt

 

 

Background: Laparoscopic sleeve gastrectomy (LSG) has increased in popularity as a definitive bariatric operation. LSG had significant morbidity like stenosis, leak along the staple line, and bleeding. Gastric leak after LSG is serious and life threating complication. It requires high index of suspicion for early diagnosis and proper management.

 

Patients and methods: From September 2012 till October 2015, 120 morbidly obese patients with a mean BMI of 49±9 underwent laparoscopic sleeve gastrectomy (LSG) at Ain Shams University hospitals. LSG was discussed in details with the patients with emphasis on the benefits and more importantly the potential complications and side effects of LSG and written consent was taken.

 

Results: 120 patients underwent LSG at Ain Shams University hospitals from them 4 patients (3.3%) developed  a gastric leak. Of these 4 patients, 3 (75%) were women and 1 (25%) man. The patients had a mean age of 42.5 years and a body mass index (BMI) of 48.4 kg/m2. Leaks were diagnosed at a median of 7 days. All cases of leakage were managed conservative by antibiotics, proton pump inhibitor (PPI), total parenteral nutrition and a self-expanding stent was placed under fluoroscopic and endoscopic control (coated metallic stents). Mean healing time was 45 days (range 21–60), mean hospital stay was 10 days. No patient required reoperation and there was no mortality.

 

Conclusion: Gastric leak after LSG is low but serious and life threating complication. It required early

diagnosis and proper management. Conservative treatments are effective but require long hospital stay.

 

Key words: Gastric leak, laparoscopic sleeve gastrectomy, morbid obesity, morbidity.

 

 

 

Introduction

Laparoscopic sleeve gastrectomy (LSG) represents a valid option for morbidly obese patients, either as a primary or as a staged bariatric procedure. Initially, LSG was conceived as a restrictive component of the biliopancreatic diversion and duodenal switch. Later on, LSG has been proposed as a step procedure in high-risk patients, followed by a second step Roux-en-Y gastric bypass or biliopancreatic diversion and duodenal switch.1

 

Recently, LSG has been proposed as a standalone bariatric procedure. Excess weight loss and remission of comorbidities have been reported to take place in a frequency comparable with other well-established procedure.2

 

LSG had significant morbidity like stenosis, leak along the staple line, and bleeding.

 

The aim of this study was to determine the rate, early diagnosis, and treatment of gastric leak after LSG in a consecutive group of obese patients.

 

Patients and methods

Patients

From  September  2012  till  October  2015,  120 morbidly obese  patients  with  a  mean  BMI  of 49±9 underwent laparoscopic sleeve gastrectomy (LSG)  at  Ain  Shams  University  hospitals.  LSG was discussed in details with the patients with emphasis on the benefits and more importantly the potential complications and side effects of LSG and written consent was taken.

 

Inclusion criteria

All  cases  were  chosen  according  to  the following criteria:

•     BMI more than 40 or more than 35 with an obesity associated co- morbidity

•    Age between 18 - 60 years

•    No endocrinal causes for obesity

•    Psychologically stable

•    Motivation & acceptance of surgical risks

 

Exclusion criteria:

•    Younger than 18 years or older than 60 years

•    Pregnant or breast feeding

•    Suffer from any severe psychiatric illness

•    Significant longstanding heart/lung disease or

other severe systemic disease

•    Sweet eaters

•    Patients  with  significant  history  of  reflux

esophagitis

•    Previous bariatric surgery

 

Operative techniques

Preoperative preparation

For prophylaxis against thromboembolic complications, all patients were given low molecular weight heparin, pneumatic intermittent pressure stocking was used intraoperatively and continued postoperatively till the patient was fully ambulant.

 

Surgical technique

The patient was put in supine, reverse Trendlenburg head up position by 30 degree with legs apart. The surgeon stood between patients’ legs with the assistant to patient’s left and camera man on patient’s right. Five ports were used: one 10 mm to the left of the umbilicus for camera, one epigastric 5mm for self-retaining laparoscopic liver retractor, two working 12/15 mm at both midclavicluar line for gastrolysis, and stapling, and one 5 mm at left anterior axillary line for the assistant.

 

Gastrolysis was started from a point 4 cm from the pylorus up to the angle of His using either ultrasonic shears or a bipolar sealing device (Ligasure). The left crus was completely exposed up to the medial border. A sleeve was created over a 36F gastric calibration tube with sequential firings of different color reloads according to stomach thickness excluding all gastric fundus as shown in Figures 1-4.

 

Methylene blue test was done at the end without over sewing the staple line with a drain left at the gastric bed.

 

 

Fig 1: Gastrolysis using Ligasure.

 

 

 

Fig 2: First reload firing.


 

 

 

Fig 3: Firing last reload with complete exclusion of the fundus.

 

 

 

 

Fig 4: Postoperative specimen for resected stomach.

 

 

 

 

Fig: 5 Stent insertion.

 

 

Statistical analysis

Required data were collected tabulated and then statistically analyzed. Analysis of data was done using  IBM  SPSS  software  (statistical  program for social science version 21). Data analysis was performed by the usual methods of descriptive statistics;  frequencies  and  percentages  for discrete variables, average, median, and standard deviations for continuous variables. The results were significant (S) with P<0.05 & highly significant (HS) with P<0.01. P≥0.05 was regarded non- significant (NS).

 

Results

Enrolled patients

From September 2012 till October 2015, 120 morbidly obese patients with a mean BMI of 49±9 underwent laparoscopic sleeve gastrectomy (LSG) at Ain Shams University hospitals. There were ninety women and thirty men with a mean age of

39 (18–60). Female: male ratio was 75:25, BMI was 49±9 (range: 40-58) kg/m2, with mean body weight 135 (105-165) kg (Table 1).

 

Table 1: Patient demographics

No. of patients                          120

Age (year)                                39 (range 18-60)

Sex

Female                                  90 (75%) Male      30 (25%) Preoperative BMI (kg/m2)            49±9 (40-58) Preoperative Weight (kg)     135 (105-165)

 

120 patients underwent LSG at Ain Shams University hospitals from them 4 patients (3.3%) developed a gastric leak. Of these 4 patients,

3 (75%) were women and 1 (25%) man. The patients had a mean age of 42.5 years and a body mass index (BMI) of 48.4 kg/m2. The 116 patients who underwent LSG without a leak served as a control group.

 

Methylene blue test was done routinely at the end of surgery without over sewing the staple line. All patients except one showed no intraoperative leakage. This leak was identified and sutured, with a consequent negative intraoperative dye test. Unfortunately, the patient leaked postoperatively

(Table 2).

 

 

Leak        Control       P Value

No. of patients    4 (3.3%)  116 (96.7%)       0.7

 

 

Patients with gastric leak presented with abdominal pain, fever, tachycardia, tachypnea, and increased white blood cell (WBC) and C-reactive protein (CRP) levels. A leak was clinically suspected and later confirmed by imaging.

 

Leaks were diagnosed at a median of 7 days (range,  1–30  days)  postoperatively:  1  (25%) early (within 3 days), 2 (50%) intermediately (from 7–14 days), and 1 (25%) late (>14 days).

 

In all cases the leak site was in the gastro esoph-ageal junction area.

 

All cases of leakage were managed conservative by antibiotics, proton pump inhibitor (PPI), total parenteral nutrition, drainage of any collection by intervention radiology and a self-expanding stent was placed under fluoroscopic and endoscopic control (coated metallic stents) (Figure 5). Radiological controls were performed weekly in order to check the correct stent position. In one patient the X-ray control showed a stent migration and the persistence of the fistula. The migrated stent  was  removed  endoscopically and  a  new stent was positioned. Stents were left in place for a mean time of 45 days (range 30–60 days) with healing of the leaks in all patients. Mean healing time was 45 days (range 21–60). 

Mean hospital stay was 10 days. Weekly x-ray was done at patients follow up. No patient required re- operation and there was no mortality.

 

Discussion

LSG is well accepted as a definitive bariatric procedure with low morbidities and acceptable weight loss results. The LSG is a straightforward procedure that can be generally completed laparoscopically, even in the case of an extremely obese patient. It does not involve any digestive anastomosis; no mesenteric defects are created eliminating the risk of internal hernia.3

 

The American Society for Metabolic and Bariatric Surgery (ASMBS) Clinical Issues Committee statement quotes an overall complication rate for LSG of 0–24% and a mortality rate of 0.39%.4 Leakage after LSG is a serious and life threatening complication, it required high index of suspicion for  early  diagnosis  and  proper  management. Many studies reported its occurrence rate ranges between 0.5% and 5% of patients.1,4-7

 

In this study the leakage rate was 3.3% which is comparable with other studies.

 

Clinical presentations of leaks vary from mild symptoms, to symptoms of sepsis characterized by peritonitis, septic shock, and multi-organic failure.5,8

 

In this study all cases were mild and diagnosed early by persistent discharge from the drains and late by symptoms and signs and confirmed by radiology.

 

Routine  methylene  blue  test  have  been  used by some authors to detect intraoperative leakage.2,9,10  The idea of this methylene blue test is to detect intraoperative leakage and to repair it at the time when tissues are viable and fresh. A negative methylene blue test does not eliminate the possibility of a leak.11

 

In this study methylene blue test was done routinely in all patients at the end of surgery and was positive only in one patient. The leak was identified and sutured, with a consequent negative intraoperative dye test. Unfortunately, the patient leaked postoperatively.

 

Also postoperative contrast studies have been advised by several authors, whereas others said that over testing is unnecessary and that good clinical judgment is the key for diagnosis.2,9,12,13

 

In this study, postoperative contrast study was positive only in one patient while in another two patients  contrast  study  was  negative  till  two weeks postoperative. The most sensitive method for diagnosis of leakage is clinical with a high index of suspicion. This is consistent with similar observations in numerous reports.12,14

 

Some studies said that contrast-swallow studies are notorious for showing ‘‘normal’’ results in the presence of leaks.13,14

 

In this study gastric leakage was located near gastro esophageal junction same as other studies.11,15,16  This may be due to presence of gastric-wall heat ischemia near the staple line or surgical fault in the surgical technique causing devascularization of the gastro esophageal junction. Classic ischemic leaks have been reported to occur 5 to 7 days after surgery when wound healing is between the inflammatory and fibrosis phases.17,18

Extraluminal gastric leak can result in cutaneous fistula, peritonitis, abscess, sepsis, organ failure, and death.19

 

Dietel M et al,2   in the First International Consensus Summit for Sleeve Gastrectomy, reported treatment of leak included early over sewing, drainage (CT or open), endoscopic clipping, and persisting fistulas requiring fibrin glue, stents, Roux loop, and even total gastrectomy. In this study the patients were managed conservatively  by  keeping  the  drain  in  place. Total parenteral nutrition, high-dose proton pump inhibitors, broad spectrum antibiotics, drainage of any collection by intervention radiology and a self- expanding stent was placed under fluoroscopic and endoscopic control (coated metallic stents).

 

Enteral nutrition should be started as soon as possible during treatment since appropriate nutrition is needed to support defect closure.11,20

 

Radiological controls were performed weekly in order to check the correct stent position. In one patient the X-ray control showed a stent migration and the persistence of the fistula. The migrated stent  was  removed  endoscopically and  a  new stent was positioned. Stents were left in place for a mean time of 45 days (range 30–60 days) with healing of the leaks in all patients. Mean healing time was 45 days (range 21–60).

 

In this study mean hospital stay LOS was 10 days. Others studies have reported a mean hospital stay LOS between 3.2 and 6 days.21,22

 

Conclusion

Gastric leak after LSG is low but serious and is a life threating complication. It required early diagnosis and proper management. Conservative treatments are effective but require long hospital stay.

 

References

1.  Regan JP, Inabnet WB, Gagner M, Pomp A: Early experience with two-staged laparoscopic Roux-en-Y gastric by-pass as an alternative  in the super-super obese. Obesity Surgery 2003; 13: 861–864.

 

2. Dietel M, Crosby RD, Gagner M: The first international consensus summit for sleeve gastrectomy (SG), New York City, October 25–

27, 2007; Obesity Surgery 2008; 18: 487–496.

 

3.   Iannelli A, Facchiano E, Gugenheim J: Internal hernia after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Obes Surg 2006;

16: 1265–1271.

 

4.   Clinical Issues Committee of American Society for Metabolic and Bariatric Surgery: Sleeve gastrectomy as a bariatric procedure. Surg Obes Relat Dis 2007; 3: 573–576.

 

5. TanJ,KariyawasamS,WijeratneT:Diagnosisand management of gastric leaks after laparoscopic sleeve gastrectomy for morbid obesity. Obes Surg 2010; 20: 203–209.

 

6. Mognol P, Chosidow D, Marmuse JP: Laparoscopic sleeve gastrectomy as an initial bariatric operation for high risk patients. Initial results in 90 patients. Obes Surg 2005; 15:1124–1128.

 

7.    Baltasar A, Bou R, Bengochea M: Mil operaciones bariatricas. Cir Esp 2006; 79: 349–353.

 

8.   Nguyen NT, Nguyen X-MT, Dholakia C: The use of endoscopic  stent  in  management  of  leaks after sleeve gastrectomy. Obes Surg 2010; 20:1289–1292. 

 

9.   Gagner M, Deitel M, Kalberer TL: The Second international consensus summit for sleeve gastrectomy, March 19–21, 2009. Surg Obes Relat Dis 2009; 5: 476–485.

 

10. Kockerling F, Schug-Pass C: Gastroscopically controlled laparoscopic sleeve gastrectomy. Obes Facts 2009; 2: 15–18.

 

11. Casella G, Soricelli E, Rizzello M: Nonsurgical treatment of staple line leaks after laparoscopic sleeve gastrectomy. Obes Surg 2009: 19: 821–826.

 

12. Dallal RM, Bailey L, Nahmias N: Back to basics— clinical diagnosis in bariatric surgery: Routine drains and upper GI series are unnecessary. Surg Endosc 2007; 21: 2268–2271.

 

13. Goitein   D,   Goitein   O,   Feigin   A:   Sleeve gastrectomy:  Radiologic  patterns  after surgery. Surg Endosc 2009; 23: 1559–1563.

 

14. Bertucci  W,  White  S,  Yadegar  J:  Routine postoperative upper gastro esophageal imaging is unnecessary after laparoscopic Roux-en-Y gastric bypass. Am Surg 2006; 72:862–864.

 

15. Frezza EE, Reddy S, Gee LL, Wachtel MS: Complications after sleeve gastrectomy for morbid obesity. Obes Surg 2009; 19: 684–687.

 

16. Tucker  ON,  Szomstein  S,  Rosenthal  RJ: Indications for sleeve gastrectomy as a primary procedure for weight loss in the morbidly obese. J Gastrointest Surg 2008; 12: 662–667.

 

17. Baker RS, Foote J, Kemmeter P: The science of stapling and leaks. Obes Surg 2004; 14: 1290–1294.

 

18. Dubay DA, Franz MG. Acute wound healing: the biology of acute wound failure. Surg Clin North Am 2003; 3: 463–481.

 

19. Carucci LR,  Turner  MA,  Conklin RC:  RYGB surgery for morbid obesity: evaluation of postoperative extraluminal leaks with upper gastrointestinal series. Radiology 2006; 238:119–127.

 

20. Serra C, Baltasar A, Andreo L: Treatment of gastric leaks with coated self-expanding stents after sleeve gastrectomy. Obes Surg 2007; 17:866–872.

 

21. HamouiN,AnthoneGJ,KaufmanHS,et al:Sleeve gastrectomy in the high-risk patient. Obes Surg 2006; 16: 1445–1449.

 

22. Roa  PE,  Kaidar-Person  O,  Pinto  D,  et  al: Laparoscopic sleeve gastrectomy as treatment for morbid obesity: Technique and short term outcome. Obes Surg 2006; 16: 1323–1326.